Devyser wins Italian hospital contract worth approximately SEK 5.7 million

• Devyser Diagnostics won a renewed three-year contract worth approximately SEK 5.7 million with Milan's Ca' Granda Ospedale Maggiore Policlinico.
• The agreement doubles test volumes compared with the previous contract.
• It covers the Devyser Thalassemia genetic test and Amplicon Suite analysis software.
• The contract runs from September 1, 2026, to August 31, 2029, with a possible three-year extension.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Devyser Diagnostics AB published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.